Get Started
  • Pharmacogenomic Testing - Available Now
One Test. 1110 Genes.

Lifetime Medication Safety

Unlock Your DNA
for Better Health

Your DNA can influence how your body responds to medications. PGxME uses clinical-grade 30X Whole Genome Sequencing to identify genetic factors that may affect medication response, helping reveal which medications may require different dosing, may be less effective, or may carry an increased risk of side effects, before treatment begins.
Get Started
See Sample Report
0 +
Genes Analyzed
0 +
Medications covered
0
Therapeutic areas
0 x
WGS depth
  • One-time purchase
PGxME logo
  • Whole Genome Pharmacogenomic Analysis
  • 1,110 genes across 990+ medications
  • 350+ drugs with guideline-backed recommendations
  • All 13 therapeutic areas covered
  • Clinical-grade 30X Whole Genome Sequencing
  • PGx-enhanced array
  • Lifetime updated reports as science evolves
  • Expert clinical pharmacist review
  • Results in 5–7 business days
  • Reports for patient, doctor, and pharmacist
  • $750
Order Your Test Kit Now

Simple cheek swab. No blood draw. No lab visit.

  • HIPAA & GDPR Compliant
  • CAP Accredited Lab Partner
  • Non-regulated SaaS (Health Canada & CMS)
  • 7 Patents Filed

Why This Matters

The Problem with
"One-Size-Fits-All" Medication

Your genes influence how you absorb, metabolize, and respond to medications. The same drug at the same dose can heal one person and harm another.
icon Adverse Drug Reactions Deaths annually from ADRs
0
Annual deaths from ADRs
Adverse drug reactions are the 4th leading cause of death in the US, from medications prescribed correctly.
icon $136B Annual cost to healthcare
$ 0 B
Annual cost to healthcare
Preventable medication harm costs the US healthcare system $136 billion every year in hospitalizations and complications.
icon less than 1% receive pharmacogenomic testing
0 %
Carry actionable variants
Nearly everyone carries genetic variants that affect drug response, yet less than 1% receive pharmacogenomic testing.
  • How PGxME help address this
  • We identify which drugs will work, which won't, and which could cause harm, before the first dose. PGx-guided prescribing reduces ADRs by up to 39% and hospitalizations by up to 53%.

Comprehensive Coverage

All Therapeutic Areas. One Test.
PGxME covers every medical specialty, from cardiology to oncology and pain management.
  • Cardiology
  • Infectious Disease
  • Transplant Medicine
  • Dermatology
  • Psychiatry
  • Gastroenterology
  • Endocrinology
  • Oncology
  • Neurology
  • Pulmonology
  • Pain Management
  • Rheumatology
  • Urology
PGxME logo

How PGxME Works

Order & Swab

Order your kit online. When it arrives, swab the inside of your cheek for 30 seconds and mail it back in the prepaid envelope.

Lab Analysis

Your sample undergoes clinical-grade 30X Whole Genome Sequencing. Sample status could be tracked on PGxME dashboard.

Get Your Results

Receive your personalized report, reviewed by a multidisciplinary team of experts, including clinical pharmacists and bioinformaticians.

Your report updates for life as new research and guidelines emerge, at no extra cost.

Order Now

PGxME for Healthcare Providers

Collecting the Samples

Healthcare systems receive barcoded OCD-100 collection kits and provide patient samples, with each kit linked to the patient at collection.

Tracking the Samples

Sample status could be tracked on the PGxME dashboard, giving your team visibility from kit registration through to laboratory analysis.

Getting the Results

PGxME platform will provide personalized reports reviewed by multidisciplinary experts, including clinical pharmacists and clinical bioinformaticians.

Simple cheek swab for your patients. No blood draw. No lab visit. Reports update for life as new research and guidelines emerge, at no extra cost.
Contact Us for More Details

Clinical Evidence

Validated by Science, Trusted by Institutions
Our platform is built on a deterministic multi-agent architecture, not a general-purpose chatbot. Every output is consistent, reproducible, and traceable.
icon Patients Carry Actionable Variants
0 %
Carry Actionable Variants

Nearly all patients carry genetic variants that affect drug response, confirming the universal relevance of pharmacogenomic testing.

Pilon et al., Pharmacogenomics 2026 (PMID: 41524197)
icon ADR Risk Reduction
Up to 0 %
ADR Risk Reduction
PGx-guided prescribing can reduce adverse drug reaction risk by up to 39%, based on MyEngene’s analysis of FDA FAERS adverse event reporting data.
MyEngene FDA FAERS Analysis
icon Fewer Hospitalizations
Up to 0 %
Fewer Hospitalizations
Drug-related hospitalizations reduced by up to 53% when prescribing is guided by pharmacogenomic data, validated through FDA adverse event analysis.
MyEngene FDA FAERS Analysis
MyEngene® Platforms Mobile App image 001

Real Outcomes

Precision Medicine in Action

See how a MyEngene® report changed a patient's treatment and their life.
  • Before MyEngene Report
Prescribed Dose
Rosuvastatin 40 mg/day
Standard dose for high cholesterol
LDL Cholesterol
180 mg/dL
Baseline, before lipid-lowering therapy
Patient Experience
Experiencing side effects at high dose
  • After MyEngene Report
Adjusted Dose
Rosuvastatin 20 mg/day
50% stain dose reduction, genotype-guided, plus combination therapy with an additional drug
LDL Cholesterol
~70 mg/dL
Projected; ~82 mg/dL on 40 mg alone
Patient Experience
"Felt much better" after dose reduction
  • MyEngene® Insight
  • Genotyping identified SLCO1B1 poor function and ABCG2 decreased function, variants in the transporters that carry rosuvastatin into the liver and limit its uptake from the gut. Both raise rosuvastatin blood levels and the risk of muscle-related side effects. CPIC guidelines cap rosuvastatin at 20 mg/day for this genotype and add a non-statin agent when further LDL lowering is needed. Here, half the statin dose delivered lower LDL than 40 mg alone.
  • Watch Demo

PGxME Overview

The same drug at the same dose can heal one person and harm another.

Your DNA may determines how you respond to medication. MyEngene® analyzes your DNA to identify which medications will work, which won’t, and which could cause harm before the first dose. Watch how PGxME makes every prescription safer.

Your Data, Your Control

Protected by the Highest Standards

Encrypted & Anonymized
Your genetic data is safeguarded with enterprise-grade encryption and anonymization at every stage.
Global Compliance
HIPAA, GDPR, PIPEDA, and CCPA compliant, exceeding global health privacy regulations.
You Control Access
You decide who sees your report. Share with your doctor, pharmacist, or family, on your terms.
Never Sold
Your genetic data is never sold, shared with insurers, or used for purposes beyond your care.
  • Right Drug, Right Dose
PGxME logo
  • Whole Genome Pharmacogenomic Analysis
One test. Lifetime protection.
Because safer medication shouldn’t be a matter of luck.
Order Your Test Kit Now
Simple cheek swab. No blood draw. No lab visit.